Venrock Healthcare Capital Partners II LP Net Worth - Insider Trades and Bio as of Jul 15, 2026

Tricida, Inc.SEC CIK: 0001602264

Estimated Net Worth

Last Updated: May 19, 2026 03:40 AM EST

Transaction Summary

Total Transactions45

Buy-Sell Ratio5.80

Buy Transactions29

Sell Transactions5

Transaction Volume

Total Volume$66.44M

Net Volume$105.05M

Buy Volume$85.74M

Sell Volume-$19.30M

Trade Analysis

AVG Trade Size$1.48M

Largest Trade$13.80M

Most Active MonthJun

Most Active Year2022

Trading Sentiment

OverallBullish

Recent TradeSelling

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Venrock Healthcare Capital Partners II, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Shockwave Medical, Inc., KalVista Pharmaceuticals, Inc., Altimmune, Inc., Unum Therapeutics Inc., Bellerophon Therapeutics, Inc., ARCA biopharma, Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and Avalanche Biotechnologies, Inc..

Holdings & Transactions

tricida, inc.

Updated: Oct 26, 2022

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.63	6.45M	$0.54	-$3.50M	Oct 26, 2022	3.75M	Sale	—	Oct 24 - 26	View
From 4	0.04	351.87K	$10.68	$3.76M	Oct 20, 2022	10.20M	Purchase	—	Oct 18 - 19	View
From 4	0.02	174.97K	$11.68	$2.04M	Oct 17, 2022	9.85M	Purchase	—	Oct 13 - 17	View
From 4	0.01	134.21K	$11.91	$1.60M	Oct 11, 2022	9.68M	Purchase	—	Oct 07 - 11	View
From 4	0.02	223.10K	$11.81	$2.63M	Oct 06, 2022	9.54M	Purchase	—	Oct 04	View
From 4	0.05	436.92K	$10.75	$4.70M	Oct 03, 2022	9.32M	Purchase	—	Sep 29 - 03	View
From 4	0.07	587.21K	$8.90	$5.23M	Sep 28, 2022	8.88M	Purchase	—	Sep 26 - 28	View
From 4	0.09	686.71K	$11.53	$7.92M	Sep 07, 2022	8.29M	Purchase	—	Sep 02 - 07	View
From 4	0.01	50.00K	$12.20	$610.00K	Sep 01, 2022	7.61M	Purchase	—	Aug 30	View
From 4	0.00	18.90K	$9.21	$174.07K	Aug 02, 2022	7.56M	Purchase	—	Jul 29	View
From 4	0.01	74.20K	$9.26	$687.18K	Jul 25, 2022	7.54M	Purchase	—	Jul 21 - 25	View
From 4	0.02	150.00K	$9.18	$1.38M	Jul 20, 2022	7.46M	Purchase	—	Jul 18 - 20	View
From 4	0.01	94.57K	$9.88	$934.82K	Jul 14, 2022	7.31M	Purchase	—	Jul 12 - 14	View
From 4	0.01	88.20K	$9.61	$847.23K	Jul 06, 2022	7.22M	Purchase	—	Jul 01 - 05	View
From 4	0.01	62.87K	$9.76	$613.51K	Jun 30, 2022	7.13M	Purchase	—	Jun 28 - 30	View
From 4	0.07	492.02K	$10.37	$5.10M	Jun 24, 2022	7.07M	Purchase	—	Jun 22 - 24	View
From 4	0.00	5.95K	$9.69	$57.67K	Jun 21, 2022	6.58M	Purchase	—	Jun 16	View
From 4	0.02	118.05K	$8.57	$1.01M	Jun 14, 2022	6.57M	Purchase	—	Jun 10 - 14	View
From 4	0.10	588.02K	$9.65	$5.67M	Jun 09, 2022	6.45M	Purchase	—	Jun 07 - 09	View
From 4	0.03	190.87K	$9.16	$1.75M	Jun 06, 2022	5.87M	Purchase	—	Jun 02 - 06	View
From 3	—	—	—	—	Jun 06, 2022	5.67M	—	—	—	View

VTGNvistagen therapeutics, inc.

Updated: Jul 14, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.00	60.00K	$0.89	-$53.40K	Jul 14, 2022	20.64M	Sale	—	Jul 12	View
From 3	—	—	—	—	Jul 08, 2022	20.70M	—	—	—	View

ALTaltimmune, inc.

Updated: Mar 01, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Mar 01, 2021	4.50M	Acq/Dis	—	Feb 25	View
From 4	0.50	1.50M	$7.54	$11.31M	Jun 15, 2020	4.50M	Purchase	—	Jun 15	View
From 4	0.77	1.30M	$8.74	$11.40M	May 28, 2020	3.00M	Purchase	—	May 26 - 28	View
From 3	—	—	—	—	May 28, 2020	1.70M	—	—	—	View

COGTunum therapeutics inc.

Updated: Aug 18, 2020VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.12	451.00K	$2.52	$1.14M	Aug 18, 2020	4.36M	Purchase	—	Aug 14 - 18	View
From 3	—	—	—	—	Aug 18, 2020	3.90M	—	—	—	View

constellation pharmaceuticals inc

Updated: Dec 16, 2019

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.11	400.00K	$34.50	$13.80M	Dec 16, 2019	4.02M	Purchase	—	Dec 13	View
From 3	—	—	—	—	Oct 04, 2019	3.62M	—	—	—	View

SWAVshockwave medical, inc.

Updated: Mar 13, 2019VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	4.24M	—	—	Mar 13, 2019	2.12M	Options	—	Mar 11	View
From 3	—	—	—	—	Mar 06, 2019	—	—	—	—	View

KALVkalvista pharmaceuticals, inc.

Updated: Mar 20, 2019VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.24	500.00K	$28.75	-$14.37M	Mar 20, 2019	1.54M	Sale	—	Mar 18	View
From 3	—	—	—	—	Sep 10, 2018	2.04M	—	—	—	View

BLPHbellerophon therapeutics, inc.

Updated: Oct 28, 2019VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.15	1.09M	$0.48	-$524.96K	Oct 28, 2019	6.44M	Sale	—	Oct 24 - 28	View
From 4	0.02	142.86K	$0.70	$100.00K	Mar 14, 2019	7.53M	Purchase	—	Jan 23	View
From 4	0.03	210.00K	$1.20	$252.35K	Sep 17, 2018	7.39M	Purchase	—	Sep 13 - 17	View
From 4	0.07	475.00K	$1.18	$558.39K	Sep 12, 2018	7.18M	Purchase	—	Sep 10 - 12	View
From 4	0.02	160.00K	$0.86	$138.16K	Sep 07, 2018	6.70M	Purchase	—	Sep 05 - 07	View
From 4	0.09	529.37K	$0.65	$342.88K	Aug 16, 2018	6.54M	Purchase	—	Aug 14 - 16	View
From 3	—	—	—	—	Aug 16, 2018	6.01M	—	—	—	View

ABIOarca biopharma, inc.

Updated: Feb 28, 2018VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	1.54M	$0.55	-$846.91K	Feb 28, 2018	—	Sale	—	Feb 26 - 27	View
From 3	—	—	—	—	Jun 17, 2015	10.79M	—	—	—	View

ADVMavalanche biotechnologies, inc.

Updated: Aug 07, 2014VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.20	400.00K	$17.00	—	Aug 07, 2014	2.37M	Purchase	—	Aug 05	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions